本月全球药品研发进展取得成效的药物有50个,较上月减少了1个,其中进入注册阶段的药物数量略有减少,进入注册前阶段和Ⅲ期临床研究阶段的药品数量均有所增加。进入注册阶段的有28个,比上月减少4个。其中8个为全球首次注册的新活性物质、新制剂,其余20个均 This month, the global drug development made 50 achievements, a decrease of 1 last month. The number of drugs entering the registration phase decreased slightly and the number of drugs entering the pre-registration phase and the phase III clinical research increased . There are 28 entries into the registration phase, down 4 from the previous month. Eight of them are the first new active substances registered in the world, the new formulation and the remaining 20 ones